124 related articles for article (PubMed ID: 22610102)
1. Biomarkers of teratogenesis: suggestions from animal studies.
Giavini E; Menegola E
Reprod Toxicol; 2012 Sep; 34(2):180-5. PubMed ID: 22610102
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress as a mechanism of teratogenesis.
Hansen JM
Birth Defects Res C Embryo Today; 2006 Dec; 78(4):293-307. PubMed ID: 17315243
[TBL] [Abstract][Full Text] [Related]
3. Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
Wells PG; Lee CJ; McCallum GP; Perstin J; Harper PA
Handb Exp Pharmacol; 2010; (196):131-62. PubMed ID: 20020262
[TBL] [Abstract][Full Text] [Related]
4. Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice.
Lee CJ; Shibata N; Wiley MJ; Wells PG
Toxicol Sci; 2011 Jul; 122(1):157-69. PubMed ID: 21505091
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of known environmental teratogens: drugs and chemicals.
Beckman DA; Brent RL
Clin Perinatol; 1986 Sep; 13(3):649-87. PubMed ID: 3533369
[TBL] [Abstract][Full Text] [Related]
7. Biochemical toxicology of chemical teratogenesis.
Wells PG; Winn LM
Crit Rev Biochem Mol Biol; 1996 Feb; 31(1):1-40. PubMed ID: 8744954
[TBL] [Abstract][Full Text] [Related]
8. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
Fort DJ; Stover EL; Farmer DR; Lemen JK
Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
[TBL] [Abstract][Full Text] [Related]
9. Receptor-selective retinoid agonists and teratogenic activity.
Willhite CC; Dawson MI; Reichert U
Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
[TBL] [Abstract][Full Text] [Related]
10. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
Brent RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
[TBL] [Abstract][Full Text] [Related]
11. Prospects for the development of validated screening tests that measure developmental toxicity potential: view of one skeptic.
Mirkes PE
Teratology; 1996 Jun; 53(6):334-8. PubMed ID: 8910978
[TBL] [Abstract][Full Text] [Related]
12. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
[TBL] [Abstract][Full Text] [Related]
13. Teratogenicity and underlying mechanisms of homocysteine in animal models: a review.
van Mil NH; Oosterbaan AM; Steegers-Theunissen RP
Reprod Toxicol; 2010 Dec; 30(4):520-31. PubMed ID: 20656016
[TBL] [Abstract][Full Text] [Related]
14. Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture.
Robinson JF; van Beelen VA; Verhoef A; Renkens MF; Luijten M; van Herwijnen MH; Westerman A; Pennings JL; Piersma AH
Toxicol Sci; 2010 Dec; 118(2):675-85. PubMed ID: 20864626
[TBL] [Abstract][Full Text] [Related]
15. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
Webster WS; Brown-Woodman PD; Ritchie HE
Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of teratogenesis: electron transfer, reactive oxygen species, and antioxidants.
Kovacic P; Somanathan R
Birth Defects Res C Embryo Today; 2006 Dec; 78(4):308-25. PubMed ID: 17315244
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical mechanisms of mammalian teratogenesis].
Repin VS
Usp Sovrem Biol; 1978; 85(3):463-78. PubMed ID: 356453
[No Abstract] [Full Text] [Related]
18. In vitro approaches to the elucidation of mechanisms of chemical teratogenesis.
Welsch F
Teratology; 1992 Jul; 46(1):3-14. PubMed ID: 1641808
[TBL] [Abstract][Full Text] [Related]
19. Never-ending tales of the mode of the teratogenic action of thalidomide.
Neubert D
Teratog Carcinog Mutagen; 1997; 17(1):i-ii. PubMed ID: 9249924
[No Abstract] [Full Text] [Related]
20. In vitro tests in screening teratogens: considerations to aid the validation process.
Kimmel GL
Prog Clin Biol Res; 1985; 163C():259-63. PubMed ID: 3991628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
